Becton Dickinson & Co. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.Becton Dickinson & Co. (BDX) stock rose 1.24% to $153.83, outperforming the broader market which saw declines in the S&P 500 and Dow Jones. This marks the third consecutive day of gains for BDX, though it remains below its 52-week high. Trading volume was lower than average. Competitors showed mixed results: Danaher and DexCom gained, while Medtronic fell slightly.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Becton Dickinson & Co. (BDX) rose 1.24% to $153.83 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.79% to 7,515.34 and Dow Jones Industrial Average falling 0.26% to 52,498.64.
This was the stock's third consecutive day of gains.
Becton Dickinson & Co. closed 17.89% short of its 52-week high of $187.35, which the company reached on February 24th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Danaher Corp. (DHR) rose 0.56% to $200.16, Medtronic PLC (MDT) fell 0.36% to $83.57, and DexCom Inc. (DXCM) rose 1.85% to $76.35.
Trading volume (1.4 M) remained 1.6 million below its 50-day average volume of 3.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 13, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-13-26 1654ET